Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-22

Clinical Trial Update: Effect of Psiguavin for Obesity Treatment (PSIGUAVIN) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating Psiguavin for obesity is in Phase 1 and Phase 2 and is currently enrolling by invitation. The sponsor is Universidad Católica San An…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psiguavin

Snippet

Sponsor: Universidad Católica San Antonio de Murcia | Conditions: Obesity, Overweight or Obesity | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION